Knowledge Distillery

Ninety-six patients with severe COVID-19 who survived intensive care unit (ICU) admission were enrolled in this prospective longitudinal cohort study.…

The authors studied blood-brain barrier (BBB) dysfunction in patients during acute SARS-Cov2 infection (76 inpatients and 25 pre-pandemic controls).…

This longitudinal study analysed digital cognitive tests’ data measuring executive functions (EF) and working memory (WM) from 3142 older adults (> 50…

Despite the high prevalence and major disability associated with fatigue and cognitive deficits after SARS-CoV-2 infection, little is known about…

This prospective cohort study within the United Kingdom COVID Symptom Study Biobank enrolled 3335 individuals with or without SARS-CoV-2 infection…

This study investigated the rate of breakthrough SARS-CoV-2 infection and clinical outcomes in a cohort of multiple sclerosis (MS) patients who were…

There are concerns on the safety of SARS-CoV-2 vaccination in patients with a history of Guillain-Barré syndrome (GBS), chronic inflammatory…

60 hospitalized patients with COVID-19 and acute neurological symptoms, 25 (42%) of them with encephalopathy and 14 (23%) with encephalitis, were…

Little is known about trajectories of recovery 12-months after hospitalisation for severe COVID. In this article the authors conducted a prospective,…

Several concerns exist on the immunogenicity of SARS-CoV-2 vaccines in multiple sclerosis (MS) subjects due to their immunomodulating disease…

Cognitive decline is a recognized manifestation of long COVID, even among patients who experienced mild disease. However, there is no evidence…

The objective of this study was to understand the course of recovery from coronavirus disease 2019 (COVID-19) among patients with multiple sclerosis…